Beyond Opioids: A Review of Suzetrigine for Acute Pain Management
International Journal of Molecular Sciences · 10.10.2025 · 26 (20) · 9865
DOI: 10.3390/ijms26209865 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.10.2025. Verfasst von Andrew Pham und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Stony Brook Hospital, Stony Brook, NY 11794, USA. Hauptthemen laut MEDLINE: Acute Pain, Analgesics, Opioid, Pain Management. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schmerzmanagement
Abstract (Originalsprache)
The ongoing opioid epidemic in the United States highlights the need for novel analgesics with reduced risk of misuse, dependence, and adverse central nervous system effects. Suzetrigine (trade name Journavx), a first-in-class selective Nav1.8 (a sodium channel expressed in peripheral nociceptors) inhibitor, was approved by the FDA in early 2025 and marketed as the first non-opioid analgesic in over two decades. Current studies have shown that suzetrigine has potential in treating acute pain perioperatively for minimally to moderately painful ambulatory procedures. However, suzetrigine appears less potent than hydrocodone-acetaminophen in this context, and it remains unclear how effective suzetrigine is in treating more severe postoperative pain. Notably, all current studies are limited to short durations of treatment; further studies will be required to delineate suzetrigine’s long-term efficacy, safety, and addiction potential to be utilized in the management of chronic pain patients. This article provides a review of the current literature available on the use of suzetrigine in treating acute pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Stony Brook Hospital, Stony Brook, NY 11794, USA.
- Renaissance School of Medicine, Stony Brook, NY 11794, USA.
ORCID-Profile: Eman Nada, Sergio Bergese
Zitieren
APA
Pham, A., Yep, H., Wozniak, S., Javvaji, A., Nada, E., & Bergese, S. (2025). Beyond Opioids: A Review of Suzetrigine for Acute Pain Management. International Journal of Molecular Sciences, 26(20), 9865. https://doi.org/10.3390/ijms26209865
Vancouver
Pham A, Yep H, Wozniak S, Javvaji A, Nada E, Bergese S. Beyond Opioids: A Review of Suzetrigine for Acute Pain Management. International Journal of Molecular Sciences. 2025;26(20):9865. doi:10.3390/ijms26209865
BibTeX
@article{Pham2025,
author = {Pham, Andrew and Yep, Hua and Wozniak, Sebastian and Javvaji, Anisha and Nada, Eman and Bergese, Sergio},
title = {Beyond Opioids: A Review of Suzetrigine for Acute Pain Management},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {20},
pages = {9865},
doi = {10.3390/ijms26209865}
}
EUVIMED